These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 1728313

  • 1. Origin and fate of iron mobilized by the 3-hydroxypyridin-4-one oral chelators: studies in hypertransfused rats by selective radioiron probes of reticuloendothelial and hepatocellular iron stores.
    Zevin S, Link G, Grady RW, Hider RC, Peter HH, Hershko C.
    Blood; 1992 Jan 01; 79(1):248-53. PubMed ID: 1728313
    [Abstract] [Full Text] [Related]

  • 2. ICL670A: a new synthetic oral chelator: evaluation in hypertransfused rats with selective radioiron probes of hepatocellular and reticuloendothelial iron stores and in iron-loaded rat heart cells in culture.
    Hershko C, Konijn AM, Nick HP, Breuer W, Cabantchik ZI, Link G.
    Blood; 2001 Feb 15; 97(4):1115-22. PubMed ID: 11159545
    [Abstract] [Full Text] [Related]

  • 3. IRC011, a new synthetic chelator with selective interaction with catabolic red blood cell iron: evaluation in hypertransfused rats with hepatocellular and reticuloendothelial radioiron probes and in iron-loaded rat heart cells in culture.
    Rivkin G, Link G, Simhon E, Cyjon RL, Klein JY, Hershko C.
    Blood; 1997 Nov 15; 90(10):4180-7. PubMed ID: 9354689
    [Abstract] [Full Text] [Related]

  • 4. Exploring the "iron shuttle" hypothesis in chelation therapy: effects of combined deferoxamine and deferiprone treatment in hypertransfused rats with labeled iron stores and in iron-loaded rat heart cells in culture.
    Link G, Konijn AM, Breuer W, Cabantchik ZI, Hershko C.
    J Lab Clin Med; 2001 Aug 15; 138(2):130-8. PubMed ID: 11477380
    [Abstract] [Full Text] [Related]

  • 5. Iron mobilization from myocardial cells by 3-hydroxypyridin-4-one chelators: studies in rat heart cells in culture.
    Hershko C, Link G, Pinson A, Peter HH, Dobbin P, Hider RC.
    Blood; 1991 May 01; 77(9):2049-53. PubMed ID: 2018841
    [Abstract] [Full Text] [Related]

  • 6. Determinants of fecal and urinary iron excretion in desferrioxamine-treated rats.
    Hershko C.
    Blood; 1978 Mar 01; 51(3):415-23. PubMed ID: 623907
    [Abstract] [Full Text] [Related]

  • 7. Synthesis of 2-amido-3-hydroxypyridin-4(1H)-ones: novel iron chelators with enhanced pFe3+ values.
    Liu ZD, Piyamongkol S, Liu DY, Khodr HH, Lu SL, Hider RC.
    Bioorg Med Chem; 2001 Mar 01; 9(3):563-73. PubMed ID: 11310590
    [Abstract] [Full Text] [Related]

  • 8. Iron chelation studies using desferrioxamine and the potential oral chelator, 1,2-dimethyl-3-hydroxypyrid-4-one, in normal and iron loaded rats.
    Kontoghiorghes GJ, Sheppard L, Hoffbrand AV, Charalambous J, Tikerpae J, Pippard MJ.
    J Clin Pathol; 1987 Apr 01; 40(4):404-8. PubMed ID: 3584483
    [Abstract] [Full Text] [Related]

  • 9. A comparison of the iron-clearing properties of 1,2-dimethyl-3-hydroxypyrid-4-one, 1,2-diethyl-3-hydroxypyrid-4-one, and deferoxamine.
    Bergeron RJ, Streiff RR, Wiegand J, Luchetta G, Creary EA, Peter HH.
    Blood; 1992 Apr 01; 79(7):1882-90. PubMed ID: 1558978
    [Abstract] [Full Text] [Related]

  • 10. The effect of N-alkyl modification on the antimalarial activity of 3-hydroxypyridin-4-one oral iron chelators.
    Hershko C, Theanacho EN, Spira DT, Peter HH, Dobbin P, Hider RC.
    Blood; 1991 Feb 01; 77(3):637-43. PubMed ID: 1991172
    [Abstract] [Full Text] [Related]

  • 11. Iron mobilization from hepatocyte monolayer cultures by chelators: the importance of membrane permeability and the iron-binding constant.
    Porter JB, Gyparaki M, Burke LC, Huehns ER, Sarpong P, Saez V, Hider RC.
    Blood; 1988 Nov 01; 72(5):1497-503. PubMed ID: 3179437
    [Abstract] [Full Text] [Related]

  • 12. Enhancement of iron chelation by desferrioxamine entrapped in red blood cell ghosts.
    Green R, Miller J, Crosby W.
    Blood; 1981 May 01; 57(5):866-72. PubMed ID: 7214016
    [Abstract] [Full Text] [Related]

  • 13. Mechanism of in vivo iron chelation by pyridoxal isonicotinoyl hydrazone and other imino derivatives of pyridoxal.
    Hershko C, Avramovici-Grisaru S, Link G, Gelfand L, Sarel S.
    J Lab Clin Med; 1981 Jul 01; 98(1):99-108. PubMed ID: 7252329
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of iron-chelating agents in an in vivo system: potential usefulness of EHPG, a powerful iron-chelating drug.
    Hershko C, Grady RW, Link G.
    Br J Haematol; 1982 Jun 01; 51(2):251-60. PubMed ID: 7082583
    [Abstract] [Full Text] [Related]

  • 15. Effect of novel 1-alkyl-3-hydroxy-2-methylpyrid-4-one chelators on uptake and release of iron from macrophages.
    Brock JH, Licéaga J, Arthur HM, Kontoghiorghes GJ.
    Am J Hematol; 1990 May 01; 34(1):21-5. PubMed ID: 2327400
    [Abstract] [Full Text] [Related]

  • 16. Ability of the orally effective iron chelators dimethyl- and diethyl-hydroxypyrid-4-one and of deferoxamine to restore sarcolemmal thiolic enzyme activity in iron-loaded heart cells.
    Link G, Pinson A, Hershko C.
    Blood; 1994 May 01; 83(9):2692-7. PubMed ID: 8167347
    [Abstract] [Full Text] [Related]

  • 17. Modulation by iron loading and chelation of the uptake of non-transferrin-bound iron by human liver cells.
    Parkes JG, Randell EW, Olivieri NF, Templeton DM.
    Biochim Biophys Acta; 1995 Apr 13; 1243(3):373-80. PubMed ID: 7727512
    [Abstract] [Full Text] [Related]

  • 18. Contrasting interspecies efficacy and toxicology of 1,2-diethyl-3-hydroxypyridin-4-one, CP94, relates to differing metabolism of the iron chelating site.
    Porter JB, Abeysinghe RD, Hoyes KP, Barra C, Huehns ER, Brooks PN, Blackwell MP, Araneta M, Brittenham G, Singh S.
    Br J Haematol; 1993 Sep 13; 85(1):159-68. PubMed ID: 8251385
    [Abstract] [Full Text] [Related]

  • 19. Influence of iron chelators, 1,2-dialkyl-3-hydroxypyridin-4-ones, on the lipid peroxidation and glutathione level in the liver of mice.
    Eybl V, Caisová D, Koutenský J, Kontoghiorghes GJ.
    Arch Toxicol Suppl; 1991 Sep 13; 14():185-7. PubMed ID: 1805729
    [No Abstract] [Full Text] [Related]

  • 20. Development and evaluation of the improved iron chelating agents EHPG, HBED and their dimethyl esters.
    Hershko C, Grady RW, Link G.
    Haematologia (Budap); 1984 Sep 13; 17(1):25-33. PubMed ID: 6427069
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.